Allogene Therapeutics Inc Strategic Asset Allocation Index
Allogene Therapeutics Inc strategic asset allocation index. Allogene Therapeutics Inc (ALLO) has a Strategic Asset Allocation Index of 7.9% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $24.94 Million) total $24.94 Million, measured against net assets of $315.33 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ALLO equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Allogene Therapeutics Inc (2018–2024)
Strategic asset allocation index of Allogene Therapeutics Inc from 2018 to 2024. This chart shows how Allogene Therapeutics Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2018 to 2024. As of September 2025, the index stands at 7.9%, representing strategic assets of $24.94 Million against net assets of $315.33 Million USD. Check how tangible is Allogene Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Allogene Therapeutics Inc Strategic Asset Allocation Index by Year (2018–2024)
Allogene Therapeutics Inc strategic asset allocation index by year from 2018 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Allogene Therapeutics Inc from 2018 to 2024, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Allogene Therapeutics Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 19.1% | $80.67 Million | $- | $80.67 Million | $422.18 Million | ▲ +18.4 pp |
| 2023 | 0.7% | $3.65 Million | $- | $3.65 Million | $512.23 Million | ▼ -39.5 pp |
| 2022 | 40.2% | $268.40 Million | $196.43 Million | $71.97 Million | $666.88 Million | ▼ -11.1 pp |
| 2021 | 51.4% | $475.17 Million | $122.99 Million | $352.18 Million | $925.20 Million | ▲ +21.4 pp |
| 2020 | 29.9% | $323.05 Million | $118.84 Million | $204.21 Million | $1.08 Billion | ▲ +3.8 pp |
| 2019 | 26.1% | $164.16 Million | $100.94 Million | $63.21 Million | $629.02 Million | ▼ -17.1 pp |
| 2018 | 43.2% | $303.58 Million | $41.61 Million | $261.97 Million | $703.16 Million | — |